C-RAD

M&A Activity • Oct 18, 2022

C-RAD's Italian distributor announced as part of large tender

The decision for positioning technology in a country wide tender in Italy has been announced. The C-RAD distributor – Tecnosan SRL – placed first in the SGRT lot and third in the gating lot. The lots include multiple Catalyst + HD and Sentinel 4DCT systems.

The tender process is subject to an appeal period of 35 days starting today. Provided no appeal is filed, the distributor is expected to sign a purchasing contract with the tendering organization thereafter. Followed by an order to C-RAD with a total value exceeding 45 MSEK. Delivery and installation of those systems is expected to commence during spring 2023 and is expected to be completed by the end of 2024.

C-RAD will inform the market once the purchase order is received.

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

This information is information that C-Rad is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-10-18 11:10 CEST.

Attachments

C-RAD's Italian distributor announced as part of large tender